Counterfeit clippings: news in brief
The Pharmaceutical Research and Manufacturers of America (PhRMA) has been denied involvement in an ongoing lawsuit in Maine, US, which is trying to repeal a law that allows state residents to buy medicines from other countries such as Canada, reports Pharmalot. The drug industry organisation has been using the lawsuit as a platform to warn of the dangers of allowing people to import drugs from overseas, which it maintains raises the risk of exposure to falsified, expired or low quality medicines. The judge in the case has concluded however that PhRMA should be shut out from proceedings because it was unable to demonstrate how drugmakers could be harmed by the law. Responding to its exclusion, PhRMA associate general counsel John Murphy said the organisation “continues to believe that Maine’s drug importation law conflicts with FDA’s authority to regulate prescription medication distribution in the US.”
Related Posts
Quartet held for fake medical camp
Police busted a fake medical camp and arrested four posing as medical...
How e-retailers such as Flipkart, Amazon are keeping fake products at bay
Stung by instances of rogue sellers on their platform shipping dubious products,...
China’s export tax removal will thwart tungsten smugglers
China’s move to scrap export taxes on certain noble alloys will remove the...
Maple sugar makers urge FDA to crack down on fake maple products
New England maple sugar makers are urging the federal government to crack down on...